https://www.selleckchem.com/pr....oducts/Dihydroartemi
Aims To identify the clinical roles of CLDN10 in clear cell renal cell carcinoma (ccRCC). Materials methods Using data from TCGA-KIRC, GEO DataSets and laboratory experiments to determine the prognostic and clinicopathological characteristics of CLDN10. Results CLDN10 expression was remarkably reduced in ccRCC. Downregulated CLDN10 was related to metastasis and poor prognosis. Multivariate Cox analysis determined that elevated CLDN10 expression was independently correlated with longer OS and DFS. Moreover, CLDN10 e
Like
Comment
Share
